SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lorus Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?


To: marcos who wrote (120)4/22/1998 12:25:00 AM
From: trustmanic  Read Replies (1) | Respond to of 279
 
Marcos,
I'm still watching this one. Today lots of biotech traded more than 100K. NRT, NVN, IMT. I don't know much about IMT Phase III, but I'll buy some just in case it pop.
I think the best bet of biotech nowaday is something to do with Genomics. Everything seems to relate to gene. Probably IMT's cancer drug will be outdated in the future and replaced by gene therapy. The best and cheap bet is NVN. Judging from the trade pattern, something good is on the way. I checked with friends, Proteomics is a hot topics for future drug research.

George



To: marcos who wrote (120)4/22/1998 1:24:00 PM
From: Brad  Read Replies (2) | Respond to of 279
 
Welcome back to what you started, Marcos!

I've been in IMT awhile now; hoping that it has bottomed out!

Brad